ACUTE VALPROIC ACID INTOXICATION - ENHANCED DRUG CLEARANCE WITH ORAL-ACTIVATED CHARCOAL

被引：25

作者：

FARRAR, HC

HEROLD, DA

REED, MD

机构：

[1] RAINBOW BABIES & CHILDRENS HOSP,DIV PEDIAT PHARMACOL & CRIT CARE,2074 ABINGTON RD,CLEVELAND,OH 44106

[2] UNIV CALIF SAN DIEGO,DEPT PATHOL,LA JOLLA,CA 92093

[3] VET ADM MED CTR,LAB SERV,SAN DIEGO,CA

来源：

CRITICAL CARE MEDICINE | 1993年 / 21卷 / 02期

关键词：

APNEA; CHARCOAL; COMA; HALF-LIFE; NALOXONE; POISONING; PHARMACOKINETICS; PROTEIN BINDING; TOXICOLOGY; VALPROATE;

D O I：

10.1097/00003246-199302000-00026

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

[No abstract available]

引用

页码：299 / 301

页数：3

共 19 条

[1] CENTRAL NERVOUS-SYSTEM MANIFESTATIONS OF A VALPROIC ACID OVERDOSE RESPONSIVE TO NALOXONE [J].

ALBERTO, G ;

ERICKSON, T ;

POPIEL, R ;

NARAYANAN, M ;

HRYHORCZUK, D .

ANNALS OF EMERGENCY MEDICINE, 1989, 18 (08) :889-891

[2] FATALITY DUE TO MASSIVE OVERDOSE OF SODIUM VALPROATE [J].

CONNACHER, AA ;

MACNAB, MSP ;

MOODY, JP ;

JUNG, RT .

SCOTTISH MEDICAL JOURNAL, 1987, 32 (03) :85-86

[3] VALPROIC ACID - INVITRO PLASMA-PROTEIN BINDING AND INTERACTION WITH PHENYTOIN [J].

CRAMER, JA ;

MATTSON, RH .

THERAPEUTIC DRUG MONITORING, 1979, 1 (01) :105-116

[4] NALOXONE AS A GABA ANTAGONIST - EVIDENCE FROM IONTOPHORETIC, RECEPTOR-BINDING AND CONVULSANT STUDIES [J].

DINGLEDINE, R ;

IVERSEN, LL ;

BREUKER, E .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 47 (01) :19-27

[5]

Dreifuss F E, 1988, Am J Med, V84, P34, DOI 10.1016/0002-9343(88)90055-1

[6] ACUTE VALPROIC ACID OVERDOSE - CLINICAL COURSE AND PHARMACOKINETIC DISPOSITION OF VALPROIC ACID AND METABOLITES [J].

DUPUIS, RE ;

LICHTMAN, SN ;

POLLACK, GM .

DRUG SAFETY, 1990, 5 (01) :65-71

[7]

GARNIER R, 1982, NOUV PRESSE MED, V11, P678

[8] PLASMA-PROTEIN BINDING OF VALPROIC ACID IN HEALTHY SUBJECTS AND IN PATIENTS WITH RENAL-DISEASE [J].

GUGLER, R ;

MUELLER, G .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 5 (05) :441-446

[9] CLINICAL PHARMACOKINETICS OF VALPROIC ACID [J].

GUGLER, R ;

UNRUH, GEV .

CLINICAL PHARMACOKINETICS, 1980, 5 (01) :67-83

[10]

HYDEN H, 1987, ANN NEUROL, V21, P6

← 1 2 →